ArticleJournal of biochemical and molecular toxicology2026
Hesperidin Attenuates H₂O₂-Induced Neurotoxicity via Modulation of Inflammatory Pathways and MMP Activity in Differentiated SH-SY5Y Cells: In Vitro and In Silico Models.
Article in Journal of biochemical and molecular toxicology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Chronic inflammation, often aggravated by oxidative stress, is a key contributor to the pathogenesis of neurodegenerative diseases. Molecular mediators such as NF-κB, COX-2, pro-inflammatory cytokines, and matrix metalloproteinases (MMP-2/MMP-9) disrupt blood-brain barrier (BBB) integrity and promote neuronal damage. Hesperidin, a natural citrus flavonoid with low cytotoxicity and high antioxidant capacity, has shown promise as a neuroprotective agent. This study aimed to evaluate its anti-inflammatory and neuroprotective effects in differentiated SH-SY5Y neuroblastoma cells exposed to hydrogen peroxide (H₂O₂), a well-established inducer of oxidative neurotoxicity. The protective effects of Hesperidin (75 and 100 µM for 48 h), administered as both pre- and post-treatment, were evaluated through cell viability assays, assessment of oxidative stress parameters, and expression analysis of inflammatory mediators (TNF-α, IL-1β, IL-6, NF-κB, COX-2), and MMP-2/MMP-9, using ELISA and RT-qPCR. In silico molecular docking analyses were also conducted using CB-Dock2 Tools to support the experimental findings. In our results, Hesperidin significantly increased cell viability (p < 0.001) and reduced morphological damage. It also downregulated TNF-α, IL-1β, and IL-6 at both mRNA and protein levels (p < 0.05-0.005), while markedly suppressing NF-κB, COX-2, MMP-2, and MMP-9 expression (p < 0.01-0.005) and decreasing oxidative stress (p < 0.005). Molecular docking revealed strong binding affinities of Hesperidin to key inflammatory targets, particularly COX-2 (-12.2 kcal/mol) and TNF-α (-11.6 kcal/mol). These findings indicate that Hesperidin exerts potent neuroprotective effects against H
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.